Close

H.C. Wainwright Reiterates Buy Rating on Paratek Pharmaceuticals (PRTK), Cites Impressive Preclinical Results in MAC Lung Infections

Go back to H.C. Wainwright Reiterates Buy Rating on Paratek Pharmaceuticals (PRTK), Cites Impressive Preclinical Results in MAC Lung Infections
Profile Technologies, Inc. (NASDAQ: PRTK) Delayed: 2.23 --0 (-0%)
Previous Close $2.23    52 Week High $22.00 
Open $2.23    52 Week Low $9.80 
Day High $2.23    P/E N/A 
Day Low $2.23    EPS $-0.08 
Volume 7,000